검색어 : 통합검색[Gerlach Martin]
총 535건 중 535건 출력
, 44/54 페이지
-
431
-
Strength of Safety Measures Introduced by Medical Practices to Prevent a Recurrence of Patient Safety Incidents: An Observational Study
-
Mü
ller, Beate S.;
Lü
ttel, Dagmar;
Schü
tze, Dania;
Blazejewski, Tatjana;
Pommé
e, Marina;
Mü
ller, Hardy;
Rubin, Katharina;
Thomeczek, Christian;
Schadewitz, Romy;
Kintrup, Andreas;
Heuzeroth, Reiner;
Beyer, Martin;
Schwappach, David;
Hecker, Ruth;
Gerlach, Ferdinand M.;
Institute of General Practice, Goethe University Frankfurt, Frankfurt am Main, Germany;
Aktionsbü
ndnis Patientensicherheit e.V., Berlin, Germany;
Institute of General Practice, Goethe University Frankfurt, Frankfurt am Main, Germany;
Institute of General Practice, Goethe University Frankfurt, Frankfurt am Main, Germany;
Institute of General Practice, Goethe University Frankfurt, Frankfurt am Main, Germany;
Techniker Krankenkasse, Hamburg, Germany;
Techniker Krankenkasse, Hamburg, Germany;
Ä
rztliches Zentrum fü
r Qualitä
t in der Medizin, Berlin, Germany;
Ä
rztliches Zentrum fü
r Qualitä
t in der Medizin, Berlin, Germany;
Kassenä
rztliche Vereinigung Westfalen-Lippe, Dortmund, Germany;
Asklepios Kliniken GmbH & Co. KGaA, Hamburg, Germany;
Institute of General Practice, Goethe University Frankfurt, Frankfurt am Main, Germany;
Aktionsbü
ndnis Patientensicherheit e.V., Berlin, Germany;
Institute of General Practice, Goethe University Frank;
(Journal of patient safety : the official publication of National Patient Safety Foundation,
v.18,
2022,
pp.444-448)
-
432
-
The transcriptional regulator FUBP1 influences disease outcome in murine and human myeloid leukemia
-
Hoang, Van T.;
Verma, Divij;
Godavarthy, Parimala Sonika;
Llavona, Pablo;
Steiner, Marlene;
Gerlach, Katharina;
Michels, Birgitta E.;
Bohnenberger, Hanibal;
Wachter, Astrid;
Oellerich, Thomas;
Mü
ller-Kuller, Uta;
Weissenberger, Eva;
Voutsinas, Jenna M.;
Oehler, Vivian G.;
Farin, Henner F.;
Zö
rnig, Martin;
Krause, Daniela S.;
;
(Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K,
v.33,
2019,
pp.1700-1712)
-
433
-
Inflammatory neovascularization during graft-versus-host disease is regulated by α<sub>v</sub> integrin and miR-100
-
Leonhardt, Franziska;
Grundmann, Sebastian;
Behe, Martin;
Bluhm, Franziska;
Dumont, Rebecca A.;
Braun, Friederike;
Fani, Melpomeni;
Riesner, Katarina;
Prinz, Gabriele;
Hechinger, Anne-Kathrin;
Gerlach, Ulrike V.;
Dierbach, Heide;
Penack, Olaf;
Schmitt-Grä
ff, Annette;
Finke, Jü
rgen;
Weber, Wolfgang A.;
Zeiser, Robert;
Department of Hematology and Oncology,;
Department of Cardiology and Angiology, and;
Department of Nuclear Medicine, Freiburg University Medical Center, Albert-Ludwigs-University of Freiburg, Freiburg, Germany;
;
Department of Cardiology and Angiology, and;
Department of Nuclear Medicine, Freiburg University Medical Center, Albert-Ludwigs-University of Freiburg, Freiburg, Germany;
;
Department of Nuclear Medicine, Freiburg University Medical Center, Albert-Ludwigs-University of Freiburg, Freiburg, Germany;
;
Department of Nuclear Medicine, Freiburg University Medical Center, Albert-Ludwigs-University of Freiburg, Freiburg, Germany;
;
Department of Hematology, Oncology and Tumorimmunology, Charité
University Medicine Berlin, Campus Virchow Klinikum, Berlin, Germany;
;
Department of Hematology and Oncology,;
Department of Hematology and Oncology,;
Department of Pathology, Freiburg University Medical Center, and;
Department of Hematology and Oncology,;
Department of Hematolo;
(Blood,
v.121,
2013,
pp.3307-3318)
-
434
-
Evidence for Anisotropic Electronic Coupling of Charge Transfer States in Weakly Interacting Organic Semiconductor Mixtures
-
Belova, Valentina;
Beyer, Paul;
Meister, Eduard;
Linderl, Theresa;
Halbich, Marc-Uwe;
Gerhard, Marina;
Schmidt, Stefan;
Zechel, Thomas;
Meisel, Tino;
Generalov, Alexander V.;
Anselmo, Ana Sofia;
Scholz, Reinhard;
Konovalov, Oleg;
Gerlach, Alexander;
Koch, Martin;
Hinderhofer, Alexander;
Opitz, Andreas;
Brü
tting, Wolfgang;
Schreiber, Frank;
Institut fü
r Angewandte Physik, Universitä
t Tü
bingen, Tü
bingen 72076,;
Department of Physics, Humboldt-Universitä
t zu Berlin, Berlin 10099,;
Institute of Physics, Experimental Physics IV, University of Augsburg, Augsburg 86135,;
Institute of Physics, Experimental Physics IV, University of Augsburg, Augsburg 86135,;
Faculty of Physics and Material Sciences Center, Philipps-Universitä
t Marburg, Marburg 35037,;
Faculty of Physics and Material Sciences Center, Philipps-Universitä
t Marburg, Marburg 35037,;
Institute of Physics, Experimental Physics IV, University of Augsburg, Augsburg 86135,;
Institute of Physics, Experimental Physics IV, University of Augsburg, Augsburg 86135,;
Department of Physics, Humboldt-Universitä
t zu Berlin, Berlin 10099,;
Max IV Laboratory, Lund University, Lund SE-221 00,;
Helmholtz-Zentrum Berlin fü
r Materialien und Energie GmbH, Berlin 14109,;
Dresden Integrated Center for Applied Physics;
(Journal of the American Chemical Society,
v.139,
2017,
pp.8474-8486)
-
435
-
Camptothecin and its analog SN-38, the active metabolite of irinotecan, inhibit binding of the transcriptional regulator and oncoprotein FUBP1 to its DNA target sequence <i>FUSE</i>
-
Khageh Hosseini, Sabrina;
Kolterer, Stefanie;
Steiner, Marlene;
von Manstein, Viktoria;
Gerlach, Katharina;
Trojan, Jö
rg;
Waidmann, Oliver;
Zeuzem, Stefan;
Schulze, Jö
rg O.;
Hahn, Steffen;
Steinhilber, Dieter;
Gatterdam, Volker;
Tampé
, Robert;
Biondi, Ricardo M.;
Proschak, Ewgenij;
Zö
rnig, Martin;
Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Paul-Ehrlich-Strasse 42-44, D-60596 Frankfurt/Main, Germany;
Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Paul-Ehrlich-Strasse 42-44, D-60596 Frankfurt/Main, Germany;
Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Paul-Ehrlich-Strasse 42-44, D-60596 Frankfurt/Main, Germany;
Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Paul-Ehrlich-Strasse 42-44, D-60596 Frankfurt/Main, Germany;
Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Paul-Ehrlich-Strasse 42-44, D-60596 Frankfurt/Main, Germany;
Department of Internal Medicine I, University Hospital Frankfurt, Theodor-Stern-Kai 7, D-60590 Frankfurt/Main, Germany;
Department of Internal Medicine I, University Hospital Frankfurt, Theodor-Stern-Kai 7, D-60590 Frankfurt/Main, Germany;
Department of Internal Medicine I, University Hospital Frankfurt, Theodor-Stern-Kai;
(Biochemical pharmacology,
v.146,
2017,
pp.53-62)
-
436
-
Assessing quality of care for the dying from the bereaved relatives’ perspective: Using pre-testing survey methods across seven countries to develop an international outcome measure
-
Mayland, Catriona Rachel;
Gerlach, Christina;
Sigurdardottir, Katrin;
Hansen, Marit Irene Tuen;
Leppert, Wojciech;
Stachowiak, Andrzej;
Krajewska, Maria;
Garcia-Yanneo, Eduardo;
Tripodoro, Vilma Adriana;
Goldraij, Gabriel;
Weber, Martin;
Zambon, Lair;
Passarini, Juliana Nalin;
Saad, Ivete Bredda;
Ellershaw, John;
Haugen, Dagny Faksvå
g;
Palliative Care Institute, Cancer Research Centre, University of Liverpool, Liverpool, UK;
Interdisciplinary Palliative Care Unit, Department of Medicine, University Medical Center of Johannes Gutenberg University Mainz, Mainz, Germany;
Regional Centre of Excellence for Palliative Care, Western Norway, Haukeland University Hospital, Bergen, Norway;
Department of Clinical Medicine (K1), University of Bergen, Bergen, Norway;
Department of Palliative Medicine, Poznan University of Medical Sciences, Poznan, Poland;
Sue Ryder House, Pallmed, Bydgoszcz, Poland;
Sue Ryder House, Pallmed, Bydgoszcz, Poland;
Mutualista Hospital Evangé
lico, Montevideo, Uruguay;
Pallium Latinoamé
rica, Buenos Aires, Argentina;
Hospital Privado Universitario de Có
rdoba, Có
rdoba, Argentina;
Interdisciplinary Palliative Care Unit, Department of Medicine, University Medical Center of Johannes Gutenberg University Mainz, Mainz, Germany;
Department of Internal Medicine, Campinas St;
(Palliative medicine,
v.33,
2019,
pp.357-368)
-
437
-
HIF2α is a direct regulator of neutrophil motility
-
Sormendi, Sundary;
Deygas, Mathieu;
Sinha, Anupam;
Bernard, Mathilde;
Krü
ger, Anja;
Kourtzelis, Ioannis;
Le Lay, Gregoire;
Sá
ez, Pablo J.;
Gerlach, Michael;
Franke, Kristin;
Meneses, Ana;
Krä
ter, Martin;
Palladini, Alessandra;
Guck, Jochen;
Coskun, Ü
nal;
Chavakis, Triantafyllos;
Vargas, Pablo;
Wielockx, Ben;
Institute of Clinical Chemistry and Laboratory Medicine, Technische Universitä
t Dresden, Dresden, Germany;
;
Institut Curie, Paris Sciences et Lettres (PSL) Research University, Centre National de la Recherche Scientifique (CNRS), Unité
Mixte de Recherche (UMR) 144, Paris, France;
;
Institute of Clinical Chemistry and Laboratory Medicine, Technische Universitä
t Dresden, Dresden, Germany;
;
Institut Curie, Paris Sciences et Lettres (PSL) Research University, Centre National de la Recherche Scientifique (CNRS), Unité
Mixte de Recherche (UMR) 144, Paris, France;
;
Institute of Clinical Chemistry and Laboratory Medicine, Technische Universitä
t Dresden, Dresden, Germany;
;
Institute of Clinical Chemistry and Laboratory Medicine, Technische Universitä
t Dresden, Dresden, Germany;
;
Institut Curie, Paris Sciences et Lettres (PSL) Research University, Centre National de la Recherche Scientifique (CNRS), Unité
Mixte de Recherche (UMR) 144, Paris, France;
;
(Blood,
v.137,
2021,
pp.3416-3427)
-
438
-
Tumor growth patterns of MGMT-non-methylated glioblastoma in the randomized GLARIUS trial
-
Schaub, Christina;
Kebir, Sied;
Junold, Nina;
Hattingen, Elke;
Schä
fer, Niklas;
Steinbach, Joachim P.;
Weyerbrock, Astrid;
Hau, Peter;
Goldbrunner, Roland;
Niessen, Michael;
Mack, Frederic;
Stuplich, Moritz;
Tzaridis, Theophilos;
Bä
hr, Oliver;
Kortmann, Rolf-Dieter;
Schlegel, Uwe;
Schmidt-Graf, Friederike;
Rohde, Veit;
Braun, Christian;
Hä
nel, Mathias;
Sabel, Michael;
Gerlach, Rü
diger;
Krex, Dietmar;
Belka, Claus;
Vatter, Hartmut;
Proescholdt, Martin;
Herrlinger, Ulrich;
Glas, Martin;
;
(Journal of cancer research and clinical oncology,
v.144,
2018,
pp.1581-1589)
-
439
-
Prescribers' compliance with summary of product characteristics of dabigatran, rivaroxaban and apixaban—A European comparative drug utilization study
-
Rottenkolber, Marietta;
Schmiedl, Sven;
Ibá
nez, Luisa;
Sabaté
, Mò
nica;
Ballarí
n, Elena;
Vidal, Xavier;
Leon‐
Muñ
oz, Luz Marí
a;
Huerta, Consuelo;
Martin Merino, Elisa;
Montero, Dolores;
Gasse, Christiane;
Andersen, Morten;
Aakjær, Mia;
De Bruin, Marie Louise;
Gerlach, Roman;
Tauscher, Martin;
Souverein, Patrick C.;
van den Ham, Rianne;
Klungel, Olaf;
Gardarsdottir, Helga;
Diabetes Research Group, Medizinische Klinik und Poliklinik IV, Klinikum der Universitaet Muenchen, Munich, Germany;
Philipp Klee‐
Institute for Clinical Pharmacology, Helios University Hospital Wuppertal, Wuppertal, Germany;
Fundació
Institut Català
de Farmacologia (FICF), Department of Clinical Pharmacology, Department of Pharmacology, Toxicology and Therapeutics, Hospital Universitari Vall d'Hebron, Universitat Autò
noma de Barcelona, Barcelona, Spain;
Fundació
Institut Català
de Farmacologia (FICF), Department of Clinical Pharmacology, Department of Pharmacology, Toxicology and Therapeutics, Hospital Universitari Vall d'Hebron, Universitat Autò
noma de Barcelona, Barcelona, Spain;
Fundació
Institut Català
de Farmacologia (FICF), Department of Clinical Pharmacology, Depa;
(Basic & clinical pharmacology & toxicology,
v.128,
2021,
pp.440-454)
-
440
-
ERGO2: A Prospective, Randomized Trial of Calorie-Restricted Ketogenic Diet and Fasting in Addition to Reirradiation for Malignant Glioma
-
Voss, Martin;
Wagner, Marlies;
von Mettenheim, Nina;
Harter, Patrick N.;
Wenger, Katharina J.;
Franz, Kea;
Bojunga, Jö
rg;
Vetter, Manuela;
Gerlach, Ruediger;
Glatzel, Michael;
Paulsen, Frank;
Hattingen, Elke;
Baehr, Oliver;
Ronellenfitsch, Michael W.;
Fokas, Emmanouil;
Imhoff, Detlef;
Steinbach, Joachim P.;
Rö
del, Claus;
Rieger, Johannes;
Dr Senckenberg Institute of Neurooncology, University Hospital Frankfurt, Goethe University;
University Cancer Center Frankfurt, University Hospital Frankfurt, Goethe University;
Dr Senckenberg Institute of Neurooncology, University Hospital Frankfurt, Goethe University;
University Cancer Center Frankfurt, University Hospital Frankfurt, Goethe University;
University Cancer Center Frankfurt, University Hospital Frankfurt, Goethe University;
University Cancer Center Frankfurt, University Hospital Frankfurt, Goethe University;
Department of Medicine 1, University Hospital Frankfurt, Goethe University;
Dr Senckenberg Institute of Neurooncology, University Hospital Frankfurt, Goethe University;
Department of Neurosurgery, HELIOS Hospital Erfurt;
(International journal of radiation oncology, biology, physics,
v.108,
2020,
pp.987-995)